| Melissa Lacy, FNP | |
|
189 Monroe Pl Ste 104, Ashland City, TN 37015-4940 | |
| (855) 632-3278 | |
| Not Available |
| Full Name | Melissa Lacy |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 189 Monroe Pl Ste 104, Ashland City, Tennessee |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356784748 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 17587 (Tennessee) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Melissa Lacy, FNP Po Box 1258, Waynesboro, TN 38485-1258 Ph: () - | Melissa Lacy, FNP 189 Monroe Pl Ste 104, Ashland City, TN 37015-4940 Ph: (855) 632-3278 |
News Archive
This symposium will provide information to educate physicians, psychiatrists and other medical and mental health-care professionals about the possibility of neurological repercussions to post-infectious syndromes.
The Juvenile Diabetes Research Foundation (JDRF) and Amylin Pharmaceuticals, Inc. announced today that they entered into a research collaboration agreement to provide financial support for a clinical proof-of-concept study to investigate the effects of metreleptin, an analog of the human hormone leptin, in patients with type 1 diabetes. Researchers at The University of Texas (UT) Southwestern Medical Center will conduct the study.
Royal Philips a globally leading heath technology company, has announced that Lumify, a smart device ultrasound solution for use at the point of care, is available in the UK. Philips' new ultrasound digital health device connects off-the-shelf compatible smart devices, a mobile application, advanced ultrasound transducer technology, integrated IT and support services to help healthcare providers improve patient care while potentially reducing ultrasound associated costs.
PaxVax Inc, which develops and commercializes innovative vaccines against infectious diseases in a socially responsible manner, today announced that it has commenced its Phase 3 clinical trial program for its single-dose oral cholera vaccine candidate, PXVX0200 (also known as CVD 103-HgR). Approximately 3,000 participants will be enrolled in this pivotal program, which is comprised of cholera challenge, safety, and immunogenicity studies.
Think that colds and flu are easy to catch, hard to avoid and impossible to treat? That nobody ever dies of a cold? That's all wrong, say the medics and scientists at a new research centre which launches today (Monday 2 June).
› Verified 6 days ago
Mrs. Rachel Paige Young, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 111 Pemberton Dr, Ashland City, TN 37015 Phone: 731-394-1145 | |
Kelsie Hannah, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 342 Frey St, Ashland City, TN 37015 Phone: 615-792-1199 Fax: 615-792-9331 | |
Terry Lee Roberts, FNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 500 Tennessee Waltz Pkwy, Ashland City, TN 37015 Phone: 866-362-9898 | |
Suzanne Lee, NURSE PRACTITIONER Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 162 County Services Dr, 200, Ashland City, TN 37015 Phone: 615-792-4318 Fax: 615-792-6794 | |
Lindsey St Cyr, APN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 313 N Main St, 2nd Floor, Ashland City, TN 37015 Phone: 731-792-1911 Fax: 731-792-0314 | |
Tracy Ann Oros, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 150 Hutton Pl, Ashland City, TN 37015 Phone: 615-792-2223 Fax: 615-792-2792 |